TopgOptions

BYSI BeyondSpring Price Target

Pembelian
NASDAQ:BYSI   BeyondSpring, Inc.
BYSI BeyondSpring drug, plinabulin, increased overall survival and improved other measures of disease while staving off a dangerous side effect associated with Chemotherapy.

BeyondSpring is preparing to ask for plinabulin approval in the U.S. and China.

On 8/4/2021 J. Pantginis from HC Wainwright brokerage Upgraded BYSI BeyondSpring from Neutral to Buy giving a Price Target of $100.00

My price target is the all time high resistance of 48usd until we hear some news from the FDA.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.